Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NC/Greensboro
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Greensboro, NC

Studies commonly pay $75 to $4,500 per completed study

591 clinical trials are currently recruiting participants within 30 miles of Greensboro. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

591studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Greensboro right now

Top 25 of 591 recruiting studies, sorted by proximity — each links to its official registry page

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific N/A Observational 20,000 participants sought
Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT00900471)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Cone Health Cancer Center — Greensboro, North Carolina (2.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (23.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Chronic Kidney Disease Phase 2 Interventional 465 participants sought
Brookview Hills Research Associates, LLC — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06717698)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Novant Health Forsyth Medical Center ( Site 0206) — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

BE WELL With Migraine: Brain Education and WELLness With Migraine

Migraine N/A Interventional 286 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT05987592)

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Myeloproliferative Neoplasm N/A Observational 35 participants sought
Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06480591)

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine Phase 3 Interventional 420 participants sought
Headache Wellness Center /ID# 270568 — Greensboro, North Carolina (2.5 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06810505)

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Vulvovaginal Candidiasis (VVC), Yeast Vaginitis N/A Interventional 55 participants sought
Lyndhurst Clinical Research — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Coologics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06983041)

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Complex Regional Pain Syndrome Type I Phase 3 Interventional 270 participants sought
Ambros Clinical Trial Site — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Ambros Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07210515)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Winston-Salem, North Carolina (23.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Epithelial Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 140 participants sought
Atrium Health Wake Forest Baptist Medical Center /ID# 276952 — Winston-Salem, North Carolina (23.3 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06890338)

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

Acute Myeloid Leukemia N/A Interventional 120 participants sought
Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06945042)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought
Retension Clinical Site — Asheboro, North Carolina (26.8 mi) · Sponsor: Retension Pharmaceuticals. Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07142356)

Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity

Chronic Pain, Osteoarthritis, Knee Phase 2 Interventional 38 participants sought
Wake Forest Baptist Health — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT04427709)

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma Phase 2 Interventional 396 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (23.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05633615)

Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML

Leukemia, Myeloid, Acute N/A Observational 50 participants sought
Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06580106)

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Atherosclerotic Cardiovascular Disease (ASCVD) Phase 3 Interventional 340 participants sought
Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06813911)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Winston-Salem, North Carolina (23.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Carcinoma, Non-small-Cell Lung Phase 2 Interventional 520 participants sought
Novant Health — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT05498428)

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Acute HIV Infection Phase 2 Interventional 48 participants sought
3203, Greensboro CRS — Greensboro, North Carolina (2.5 mi) · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
See eligibility & contact on ClinicalTrials.gov (NCT05719441)

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Cesarean Delivery, General Anesthesia N/A Observational 5,000 participants sought
Atrium Health Wake Forest Baptist Medical Center — Winston-Salem, North Carolina (23.3 mi) · Sponsor: Yale University
See eligibility & contact on ClinicalTrials.gov (NCT06030063)
Actively enrolling

Studies you may be able to join near Greensboro

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Greensboro

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Triad Clinical Trials

★ 5.0
811 Dolley Madison Rd, Greensboro, NC 27410
(336) 235-0991
"Staff is very friendly.They make sure you understand everything with the study"
— Kenyatta Spruill, 5★

Eastcoast Research

★ 5.0
1118 Grecade St #103, Greensboro, NC 27408
(336) 285-5195
"Great company and easy to work with!"
— Pearson Wynands, 5★

Peters Medical Research

★ 4.8
665 N Main St Ste 103, High Point, NC 27260
(336) 883-9773
"Very professional and kind staff & Dr."
— BRENDA LILLY, 5★

Cone Health Cancer Center at Wesley Long Hospital

★ 3.9 (44 reviews)
2400 W Friendly Ave, Greensboro, NC 27403
(336) 832-1100
"Really terrible with keeping appointments and long wait times. I had appointments scheduled and rescheduled without notice. Providers were late and c…"
— Carlee Watley, 2★

Central Carolina Surgery

★ 2.9
1002 N Church St Ste 302, Greensboro, NC 27401
(336) 387-8100
"They insist on me paying my deductible of 3000 to them before they will process my FMLA paperwork. I have explained over and over that I have claims …"
— Janet Cosner, 1★

UNCG Office of Research and Engagement

MHRA building, 1111 Spring Garden St #1601, Greensboro, NC 27412
(336) 334-4623

Cone Health Cancer Center: Matthew A. Manning, MD

★ 3.7
2400 W Friendly Ave, Greensboro, NC 27403
(336) 832-1100
"At the Cancer Center they make you very warm and welcome to the concerns and needs that you have"
— Angela Watson, 5★

Cone Health Guilford Neurologic Associates

★ 3.1
912 Third St #101, Greensboro, NC 27405
(336) 273-2511
"This review is more for the calling the office. I received a phone call and literally returned the call but their office is closed message came on b/…"
— Bee Bee, 3★

Center For Clinical Research

★ 3.0 (4 reviews)
145 Kimel Park Dr #330, Winston-Salem, NC 27103
(336) 765-6181
"ABSOLUTELY NO. ABSOLUTELY NOT.<br>You can thank me later."
— K, 1★

Clinical trials in Greensboro: what's recruiting

The Greensboro area currently has 591 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Greensboro, the most active research areas are:

  • Cancer & Oncology14 studies
  • Liver & Kidney2 studies
  • Brain & Mental Health2 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Greensboro, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Greensboro

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Greensboro participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How do I join a study in Greensboro, NC?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Greensboro?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Greensboro?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Greensboro.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Greensboro typically complete one or two studies per year.

Paid clinical trials near Greensboro

Other metros within reach

High Point, NC592 Burlington, NC748 Winston-Salem, NC592 Durham, NC1,669 Cary, NC1,669 Concord, NC624 Roanoke, VA194 Raleigh, NC1,661

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Greensboro Chronic Kidney Disease (HealthMatch) in Greensboro Bladder Issues Due To Spinal Cord Injury in Greensboro All conditions

More of NC

Durham1,669 Cary1,669 Raleigh1,661 Burlington748 Gastonia644 Charlotte643 Concord624 High Point592 Winston-Salem592 Fayetteville125 Asheville122

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts